Alexion to Present at the UBS Global Healthcare Conference
BOSTON--(BUSINESS WIRE)--May 13, 2019--
Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the UBS Global Healthcare Conference in New York, NY on Monday, May 20, 2019 at 11:30 a.m. ET.
An audio webcast of the presentation will be available live. You can access the webcast at: http://ir.alexion.com. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190513005793/en/
Susan Altschuller, Ph.D.
Vice President, Investor Relations
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Alexion Pharmaceuticals
Copyright Business Wire 2019.
PUB: 05/13/2019 04:30 PM/DISC: 05/13/2019 04:30 PM